Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils.
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
High titers of cryptococcal polysaccharides in the serum and spinal fluid and the lack of cellular infiltrates in the infected tissues are hallmarks of disseminated cryptococcosis. Cryptococcal polysaccharides given intravenously to mice inhibit the influx of leukocytes into sites injected with inflammatory mediators. The purpose of this investigation was to determine if cryptococcal polysaccharides, i.e., glucuronoxylomannan (GXM), galactoxylomannan, and mannoprotein, affect expression of molecules on the surface of neutrophils that are important in extravasation. GXM in the absence of serum was shown to induce human neurophils to shed L-selectin, a molecule needed in the first step of neutrophil movement into tissues. In the presence of serum, GXM caused a further shedding of L-selectin. Shedding of L-selectin was evident by reduced amounts of L-selectin on the neutrophils treated with GXM and by increased levels of soluble L-selectin in the GXM-treated neutrophil supernatants. GXM also stimulated neutrophils to have reduced expression of TNF receptor. In contrast, GXM-treated neutrophils showed increased levels of CD15 and CD11b, and unchanged CD16 expression. In the absence of serum, galactoxylomannan and mannoprotein did not affect L-selectin, TNF receptor, CD15, CD11b, or CD16 on neutrophils but did induce loss of L-selectin in the presence of serum. Our results indicate that cryptococcal polysaccharides, especially GXM, can cause shedding of L-selectin from the surface of neutrophils, and this may prevent neutrophils from attaching to the endothelial cell surfaces. Blockage of this early step in cell migration from the vessels into tissues may be responsible in part for reduced cellular infiltration into infected tissues of individuals with disseminated cryptococcosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kozel, T. R., Wilson, M. A., & Murphy, J. W. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.3101-3110.1991 · Cited by 86 · cited 1×
“neoformans is a strong activator of the complement cascade (34), and both GXM and MP have been previously shown to have such activity (18).”
BackgroundSelf-citationLovchik, J. A., & Lipscomb, M. F. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/9.6.617 · Cited by 48
Cited by
Chapter 4 The Capsule of the Fungal Pathogen Cryptococcus neoformans
Zaragoza, O., Rodrigues, M. L., De Jesus, M., Frases, S., Dadachova, E., & Casadevall, A. (2009) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(09)01204-0 · Cited by 457
What Makes Cryptococcus neoformans a Pathogen?
Buchanan, K. L., & Murphy, J. W. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0401.980109 · Cited by 325
Self-citationD'Souza, C. A., Alspaugh, J. A., Yue, C., Harashima, T., Cox, G. M., Perfect, J. R., & Heitman, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3179-3191.2001 · Cited by 318
Shoham, S., Huang, C., Chen, J.-M., Golenbock, D. T., & Levitz, S. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4620 · Cited by 306
Basic principles of the virulence of Cryptococcus
Zaragoza, O. (2019) · Virulence · doi:10.1080/21505594.2019.1614383 · Cited by 249
Metadata
- Authors
- Dong, Z. M., & Murphy, J. W.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-02-01
- Volume
- 97
- Issue
- 3
- Pages
- 689-698
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2070550149
- Cited by
- 114
- References
- 2
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.